Researchers must rely on trial and observation to determine how well they respond to the compound
FDA Guidance for Industry
Beyond the typical regulatory pathways mentioned above, ferroptosis is modulated by many regulators, such as p53, nuclear factor erythroid 2-related factor 2 (Nrf2) and AMP-activated protein kinase (AMPK)[37-39], among which p53 gets a lot of attention due to its controversial role in ferroptosis
Anecdotally, she says, I have heard about someone having a completely flat affect on a GLP-1 and being completely indifferent to their spouse until they went off of the medication. There are also concerns about what happens when the effects of the medication wear off
WE'RE A LONG way from recommending that people undergo genetic testing before trying out a GLP-1, but experts aren't ruling out the possibility as a potential decision-making factor
However, it may support overall hair health and potentially slow the progression of graying